Shares of Genscript Biotech Co. (OTCMKTS:GNNSF – Get Free Report) were down 3.9% during trading on Friday . The company traded as low as C$1.22 and last traded at C$1.22. Approximately 1,500 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 49,468 shares. The stock had previously closed at C$1.27.
Genscript Biotech Trading Down 3.9 %
The firm’s fifty day moving average price is C$1.29 and its two-hundred day moving average price is C$1.40.
About Genscript Biotech
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, the People's Republic of China, Japan, the other Asia Pacific regions, and internationally. The company operates through four segments: Life Science Services and Products; Biologics Development Services; Industrial Synthetic Biology Products; and Cell Therapy.
Read More
- Five stocks we like better than Genscript Biotech
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Earn High Dividends With 2 Top REITs Set to Perform in 2025
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Oilfield Leader SLB: An AI Name You Need to Know
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- Top ETFs That Beat the Market in 2024 and Could Do It Again
Receive News & Ratings for Genscript Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genscript Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
